Published by Global Banking & Finance Review®
Posted on September 26, 2025
1 min readLast updated: January 21, 2026
Add as preferred source on GoogleBritain is negotiating with the US to secure better terms on proposed 100% pharmaceutical tariffs, crucial for the UK's economy.
LONDON (Reuters) -Britain on Friday said it was pressing the United States on pharmaceutical tariffs in hope of a beneficial outcome, after President Donald Trump said a new 100% tariff would apply to firms unless they build a manufacturing presence in the country.
"We know this will be concerning for industry, which is why we've been actively engaging with the U.S. and will continue to do so over the coming days," a British government spokesperson said.
"Sectors such as pharmaceuticals are critical to our economy... so we will continue to press the U.S. for outcomes that reflect the strength of our relationship and deliver real benefits for UK industry."
(Reporting by Alistair Smout; editing by William James)
Britain is actively pressing the United States for a beneficial outcome regarding pharmaceutical tariffs, following President Trump's announcement of a potential 100% tariff.
Pharmaceuticals are critical to the UK economy, prompting the government to engage with the US to ensure outcomes that reflect the strength of their relationship.
A British government spokesperson stated that they are aware of the industry's concerns and are actively engaging with the US to address these issues.
Explore more articles in the Headlines category
